CATALYZING, SUPPORTING, FUNDING & HARMONIZING RESEARCH
The COVID-19 Immunity Task Force (CITF) was created in late April 2020 with the goal of catalyzing, supporting, funding and harmonizing research into COVID-19 immunity to inform Canadian policymakers, allowing them to make evidence-based decisions.
The Task Force is overseen by a Leadership Group that includes leading scientists and experts from universities and healthcare facilities across Canada who, on top of their many other duties, volunteer their time to the CITF.
The CITF is supporting numerous studies that aim to:
- Determine the extent of SARS-CoV-2 infection and vaccination in the general Canadian population as well as in specific communities and priority populations;
- Understand the nature of immunity arising from SARS-CoV-2 infection;
- Develop improved antibody testing methods;
- Monitor the effectiveness and safety of vaccines as they are rolled out across Canada and in specific sub-groups of the population such as children;
- Determine the need for, and optimal timing of, booster shots;
- Develop models of population immunity models to guide our national public health efforts as the pandemic continues to evolve; and
- Explore cross-cutting themes.
The Task Force and its Secretariat work closely with a range of partners, including governments, public health agencies, institutions, health organizations, research partners, other task forces, and engages communities and stakeholders.